Editorial
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jan 21, 2025; 31(3): 100393
Published online Jan 21, 2025. doi: 10.3748/wjg.v31.i3.100393
Table 1 Red cell distribution width/platelet ratio in non-hepatic conditions
Ref.
Method
Findings
Conclusion
Acute conditions
Cetinkaya et al[43], 2014Totally 102 patients with AP were recruitedRPR with a cutoff value of 0.000067 presented an area under the receiver operating characteristic curve of 0.783 (95%CI: 0.688-0.878) and predicted the mortality of approximately 80% of the patientsRPR is a valuable biomarker of mortality in AP
Pusuroglu et al[44], 2015 Totally 470 consecutive patients with STEMI submitted for primary PCI were prospectively enrolledAt LRA, high RPR was an independent predictor of one-year cardiovascular mortality (P = 0.003, OR = 3.106, 95%CI: 1.456-6.623)RPR is an inexpensive and readily available biomarker which offers additional risk stratification in predicting long-term MACE and cardiovascular mortality in STEMI
Celık et al[42], 2015Totally 580 STEMI patients were divided into two groups according to thrombolysis in myocardial infarction flow grades after primary PCIAt LRA, RPR was among the independent predictors of no-reflow after primary PCI. In its turn, being in the no-reflow group compared to the reflow patients was associated with higher odds of in-hospital MACE, and cardiovascular mortalityRPR is among the independent predictors of no-reflow and in-hospital MACE among patients with STEMI undergoing primary PCI
Karabulut and Arcagok[45], 2020 RPR was compared to C-reactive protein and procalcitonin to investigate the potential to predict EOS in newbornsRPR and other biomarkers had higher values in proven EOS than in the controlsRPR may be used in the diagnosis of EOS among newborns as a good alternative to other tools
Lehmann et al[46], 2021Totally 102 subjects with deep-seated ICH were includedAt LRA elevated RPR ≥ 0.06 was among the independent predictors of 90-day mortalityRPR, as a biomarker of inflammation, might serve for prognostic assessment in deep-seated ICH
Jiang et al[47], 2022Totally 47 individuals with MSA, 125 subjects with Parkinson’s disease, and 124 healthy controls were enrolledAt LRA, RPR was associated with the risk of MSAPatients with MSA probably have peripheral inflammatory reaction
Liu et al[48], 2022Totally 3367 patients with sepsis
were enrolled
After adjustment for confounders, high RPR was significantly associated with increased mortality both for categorical and continuous variables (adjusted HR = 1.210, 95%CI: 1.045–1.400; and adjusted HR = 2.826, 95%CI: 2.025–3.944, respectively)Elevated RPR values predict 28-day mortality in patients with sepsis
Wang et al[49], 2022 Totally 45 newborns were included in each of three groups of different severity; mild, moderate, and severe conditions based on SNAPE-IIA positive correlation was found between the SNAPE-II scores and RPR among newborns in NICUFurther to the SNAPE-II, also RPR can be used as a supplementary predictor biomarker for the assessment of neonatal morbidity and mortality in NICU
Liang et al[50], 2023 Retrospective cohort study of 2823 adults with ICHAfter adjustment for confounding factors, the 3rd tertile of RPR values, compared to the 1st tertile, was associated with increased odds of 30-day death in patients with ICH (HR = 1.37, 95%CI: 1.15–1.64)Among subjects with ICH, elevated RPR levels predict 30-day mortality
Kasirer et al[51], 2024Totally 69 infants with NEC and 78 controls were enrolled RPR was significantly associated with both NEC diagnosis (P < 0.0001) and mortality (P = 0.01). However, at LRA only variations of platelet count from birth to diagnosis remained significantThe often-elusive attempts to definitively diagnose NEC among preterm newborns may benefit from largely available, cheap, and easily calculated platelet indices
Chronic and acute-on chronic conditions
Özer Bekmez et al[52], 2018 A cohort of 112 infants with medically treated hsPDA and 96 controls were recruitedAt LRA analysis, high RPR (OR = 3.3, 95%CI: 1.438-5.872, P < 0.05) was one of the independent risk factors for hsPDARPR is a promising biomarker for the diagnosis of hsPDA
Bilgin et al[53], 2019Totally 312 CRC patients were enrolledAmong subjects with right-sided advanced cancer, OS was statistically significantly better for those with RPR ≥ 0.05 compared to those with RPR < 0.05 (median OS; RPR ≥ 0.05: 24.8 months vs < 0.05: 13.9 months; P = 0.035)After validation, RPR can be used as a prognostic marker in CRC
Dagistan and Cosgun[54], 2019Retrospective survey of 1342 subjects submitted to cranial MRIA statistically significant difference was found in RPR values among the various study groups (Fazekas 0 to Fazekas 3) (P < 0.001)Increased RPR values may suggest higher Fazekas's score and dementia in cranial MRI studies
Guler Kazanci et al[55], 2019Totally 481 infants were recruited (169 with hsPDA and 312 controls)RPR was significantly higher in the hsPDA group (P < 0.05). At LRA RPR > 0.070 (risk ratio = 5.33; 95%CI: 3.28-8.65; P < 0.001) was among the independent predictors of hsPDAHigh RPR values in the first hours of life are a risk factor for hsPDA (and hsPDA refractive to ibuprofen treatment) in preterm infants
Chen et al[56], 2023Totally 1922 AECOPD adults participating in the MIMIC-III and MIMIC-IV; and 1738 AECOPD patients from Emergency Intensive Care Unit Collaborative Research Database were recruitedAfter adjusting for confounders, Log (RPR×1000) was associated with elevated risk of in-hospital mortality of AECOPD patients (OR = 1.36, 95%CI: 1.01–1.84)Among AECOPD patients RPR was associated with in-hospital mortality